Ault Global Holdings Inc. (NASDAQ: DPW) stock gained by 4.29% at last close while the DPW stock price surges by 7.41% in the after-hours trading session. Ault Worldwide Holdings, Inc. is a diversified holding company focused on purchasing undervalued firms and disruptive technologies having a global impact on expansion.
DPW stock’ Recent Development
Ault Global has recently stated that Adtech Pharma has hired Jodi Brichan as one of its Board of Directors. Ms. Brichan served on the Company’s board of directors until August 13, 2021. The Firm entered into a securities deal with Adtech in June 2021, allowing it to buy up to 40% of the present stock in Adtech, an innovative biotechnology company, for $3 million. The Agreement had also given the option to Adtech that they can appoint Ms. Brichan. Digital Power Lending, LLC, a fully owned subsidiary of the Company, made the Adtech investment.
About Jodi Brichan,
Jodi Brichan has more than 25 years of expertise in marketing. She works with hypergrowth healthcare industries including pharmaceuticals, medical devices, energy gadgets, and life sciences to help bring novel products to market. Ms. Brichan formerly oversaw Alcon’s pharmaceutical portfolio of ophthalmic products as a communications executive at two of the world’s top global communications networks, Omnicom and Publicis. She has joined the board of directors of healthcare and technology firms for the past five years. She graduated from Central Michigan University in Mount Pleasant, Michigan, with a B.A.A. She is the appropriate board member for Adtech because of her extensive expertise in clinical research, commercial product launches, and increasing shareholder value.
Dr. Robert Kupper, President, and CEO of Adtech commented,
Jodi Brichan has been appointed to their board of directors, something they are extremely excited about. Ms. Brichan has a wealth of experience that they believe will be helpful to Adtech. They are pleased to collaborate with her and want to expand their relationship with Ault Global Holdings to improve Adtech’s research and technology to provide medications to people in need.
